Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CONSTELLATION PHARMACEUTICALS INC (CNST) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/06/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : May 6, 2020 Constellation Pharmaceuticals, Inc. Delaware 001-38584 26-1741721 215 First Street, Suite 200 Cambridge, Massachusetts 02142 Registrant's telephone number, including area code: 714-0555 Not applicable",
"Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results"
08/14/2018 8-K Investor presentation, Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of report : August 14, 2018 Constellation Pharmaceuticals, Inc. Delaware 001-38584 26-1741721 215 First Street, Suite 200 Cambridge, Massachusetts 02142 Registrant's telephone number, including area code: 714-0555 Not applicable",
"Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial Results",
"Corporate Overview dated August 2018"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy